Author:
Bushyhead Daniel,Fishman Paul
Publisher
Springer Science and Business Media LLC
Reference6 articles.
1. US Preventive Services Task Force, Bibbins-Domingo K, Grossman DC, Curry SJ, et al. Screening for Colorectal Cancer: US Preventive Services Task Force Recommendation Statement. JAMA 2016;315:2564-2575.
2. White A., Thompson T.D., White M.C., et al: Cancer screening test use—United States, 2015. MMWR Morb Mortal Wkly Rep 2017; 66: pp. 201-206.
3. Jensen CD, Corley DA, Quinn VP, et al. Fecal immunochemical test program over 4 rounds of annual screening: a retrospective study. Ann Intern Med 2016;164:456-63.
4. Baker LC, Phillips KA, Haas JS, Liang SY, Sonneborn D. The effect of area HMO market share on cancer screening. Health Serv Res 2004;39:1751–72.
5. Shariff-Marco S, Breen N, Stinchcomb DG, Klabunde CN. Multilevel predictors of colorectal cancer screening use in California. Am J Manag Care 2013;19(3):205–216.